Interview and Research Highlights with Dr. Jacques Bergman
Dr. Bergman (Amsterdam University Medical Centers) discusses his latest research into tools for risk stratification of patients with community-based diagnosis of low-grade dysplasia.
Interview with Dr. Lucas C. Duits: Standardizing Patient Management with TissueCypher
This study evaluated the impact that variability in pathologic diagnosis has on patient care and shows that adding guidance from TissueCypher to the standard of care can improve the consistency of management and increase the percentage of progressors that receive appropriate treatment while reducing the number of non-progressors that are over treated.
Interview with Dr. Raman Muthusamy: Barrett's Conundrum
Speaking with Dr. Raman Muthusamy (Clinical Professor of Medicine, UCLA) on the challenge of risk-stratifying Barrett's esophagus patients so we can focus our effective treatments on high-risk patients and avoid overtreatment of low-risk patients.
Interview with Dr. Sri Komanduri, re: the 2022 AGA Clinical Practice Update
Castle Biosciences sat down with Dr. Sri Komanduri, Associate Chief of Gastroenterology and Hepatology at Northwestern Medicine, to discuss the American Gastroenterological Association (AGA) Clinical Practice Update, published July 01, 2022.
Search
Clinician Ordering Portal
